• Subscribe
  • Magazine
  • Past Issues
  • Surveys
  • Industry Statistics
  • About Us
  • Members Only
  • Best Places to Work
    • Recent Quotes
    My Watchlist
    Indicators
    PennEnergy Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Morphic Holding Inc (NQ: MORF )

    31.37 +2.90 (+10.19%)
    Streaming Delayed Price Updated: 3:28 PM EDT, Jun 24, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 425,626
    Open 28.95
    Bid (Size) 31.25 (4)
    Ask (Size) 31.37 (4)
    Prev. Close 28.47
    Today's Range 28.62 - 31.37
    52wk Range 19.34 - 62.08
    Shares Outstanding 36,415,045
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Morphic to Participate in Jefferies Global Healthcare Conference
    From Morphic Therapeutic
    Via GlobeNewswire
    Morphic Demonstrates Novel Real-Time Visualization of Small Molecule α4β7 Inhibition of Gut-Trafficking Cells
    From Morphic Therapeutic
    Via GlobeNewswire

    Performance

    YTD
    +8.43%
    +8.43%
    1 Month
    +1.85%
    +1.85%
    3 Month
    -2.43%
    -2.43%
    6 Month
    +4.53%
    +4.53%
    1 Year
    -45.96%
    -45.96%

    More News

    Read More
    Morphic to Participate in RBC Capital Markets Global Healthcare Conference
    From Morphic Therapeutic
    Via GlobeNewswire
    Recap: Morphic Holding Q4 Earnings
    Via Benzinga
    MORF Stock Earnings: Morphic Holding Beats EPS for Q1 2024
    Via InvestorPlace
    Morphic Announces Corporate Highlights and Financial Results for the First Quarter 2024
    From Morphic Therapeutic
    Via GlobeNewswire
    Morphic Holding, Inc. (MORF) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
    From Bronstein, Gewirtz & Grossman, LLC
    Via Business Wire
    Morphic Holding, Inc. (MORF) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
    From Bronstein, Gewirtz & Grossman, LLC
    Via Business Wire
    MORF Investor Notice: Abraham, Fruchter & Twersky, LLP Investigating Claims on Behalf of Investors of Morphic Holding, Inc.  (NASDAQ:MORF)
    From Abraham, Fruchter & Twersky, LLP
    Via GlobeNewswire
    Morphic Appoints Dr. Simon Cooper as Chief Medical Officer
    From Morphic Therapeutic
    Via GlobeNewswire
    Morphic to Participate in March Investor Conferences
    From Morphic Therapeutic
    Via GlobeNewswire
    Morphic Announces Corporate Highlights and Financial Results for the Full Year 2023
    From Morphic Therapeutic
    Via GlobeNewswire
    INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Morphic Holding, Inc. (MORF) on Behalf of Investors
    From Law Offices of Howard G. Smith
    Via Business Wire
    Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Morphic Holding, Inc. (MORF) on Behalf of Investors
    From Glancy Prongay & Murray LLP
    Via Business Wire
    The Law Offices of Frank R. Cruz Announces Investigation of Morphic Holding, Inc. (MORF) on Behalf of Investors
    From The Law Offices of Frank R. Cruz
    Via Business Wire
    Morphic to Present at the 42nd Annual J.P. Morgan Healthcare Conference
    From Morphic Therapeutic
    Via GlobeNewswire
    Robbins LLP Reminds MORF Investors that it is Investigating Morphic Holdings, Inc. on Behalf of Investors
    From Robbins LLP
    Via Business Wire
    Morphic Holding, Inc. Reminder: Robbins LLP is Investigating MORF on Behalf of Investors
    From Robbins LLP
    Via Business Wire
    Morphic to Present at November Investor Conferences
    From Morphic Therapeutic
    Via GlobeNewswire
    Morphic Announces Corporate Highlights and Financial Results for the Third Quarter 2023
    From Morphic Therapeutic
    Via GlobeNewswire
    NASDAQ: MORF Investor Notice: Investigation over Possible Securities Laws Violations by Morphic Holding, Inc.
    Via SBWire
    Morphic Holding Investigation: Johnson Fistel Encourages Shareholders with Losses to Contact the Firm Regarding Investigation
    From Johnson Fistel, LLP
    Via Business Wire
    Morphic Holding SHAREHOLDER ALERT: Johnson Fistel Encourages Morphic Holding Shareholders with Losses to Contact the Firm Regarding Investigation
    From Johnson Fistel, LLP
    Via Business Wire
    Morphic Therapeutic to Host Webcast to Present EMERALD-1 Full Data Set
    From Morphic Therapeutic
    Via GlobeNewswire
    MORF INVESTIGATION ALERT: Robbins Geller Rudman & Dowd LLP Announces Investigation into Morphic Holding, Inc. and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm
    From Robbins Geller Rudman & Dowd LLP
    Via Business Wire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.